These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 29485939
1. Circulation of Highly Drug-Resistant Clostridium difficile Ribotypes 027 and 001 in Two Tertiary-Care Hospitals in Mexico. Martínez-Meléndez A, Tijerina-Rodríguez L, Morfin-Otero R, Camacho-Ortíz A, Villarreal-Treviño L, Sánchez-Alanís H, Rodríguez-Noriega E, Baines SD, Flores-Treviño S, Maldonado-Garza HJ, Garza-González E. Microb Drug Resist; 2018 May; 24(4):386-392. PubMed ID: 29485939 [Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012. Lachowicz D, Pituch H, Obuch-Woszczatyński P. Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196 [Abstract] [Full Text] [Related]
3. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014. Freeman J, Vernon J, Pilling S, Morris K, Nicholson S, Shearman S, Longshaw C, Wilcox MH, Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes Study Group. Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403 [Abstract] [Full Text] [Related]
4. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis. Nyc O, Tejkalova R, Kriz Z, Ruzicka F, Kubicek L, Matejkova J, Kuijper E, Krutova M. Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531 [Abstract] [Full Text] [Related]
5. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications. Debast SB, Bauer MP, Sanders IM, Wilcox MH, Kuijper EJ, ECDIS Study Group. J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839 [Abstract] [Full Text] [Related]
6. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Huang H, Weintraub A, Fang H, Wu S, Zhang Y, Nord CE. Anaerobe; 2010 Dec; 16(6):633-5. PubMed ID: 20849968 [Abstract] [Full Text] [Related]
9. PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015. Karlowsky JA, Adam HJ, Kosowan T, Baxter MR, Nichol KA, Laing NM, Golding G, Zhanel GG. Diagn Microbiol Infect Dis; 2018 Jun; 91(2):105-111. PubMed ID: 29456070 [Abstract] [Full Text] [Related]
10. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years. Piepenbrock E, Stelzer Y, Berger F, Jazmati N. Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700 [Abstract] [Full Text] [Related]
12. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14. Knight DR, Giglio S, Huntington PG, Korman TM, Kotsanas D, Moore CV, Paterson DL, Prendergast L, Huber CA, Robson J, Waring L, Wehrhahn MC, Weldhagen GF, Wilson RM, Riley TV. J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017 [Abstract] [Full Text] [Related]
13. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain. Weber I, Riera E, Déniz C, Pérez JL, Oliver A, Mena A. Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477 [Abstract] [Full Text] [Related]
14. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea. Kim J, Kang JO, Pai H, Choi TY. Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765 [Abstract] [Full Text] [Related]
15. In vitro activity of surotomycin against contemporary clinical isolates of toxigenic Clostridium difficile strains obtained in Spain. Reigadas E, Alcalá L, Marín M, Pelaéz T, Martin A, Iglesias C, Bouza E. J Antimicrob Chemother; 2015 Aug; 70(8):2311-5. PubMed ID: 25876881 [Abstract] [Full Text] [Related]
16. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption. Seo MR, Kim B, Kim J, Pai H. Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866 [Abstract] [Full Text] [Related]
18. In vitro activity of MCB3681 against Clostridium difficile strains. Rashid MU, Dalhoff A, Weintraub A, Nord CE. Anaerobe; 2014 Aug; 28():216-9. PubMed ID: 25016084 [Abstract] [Full Text] [Related]
20. Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired clostridium difficile PCR ribotype 018 strains. Seo MR, Kim J, Lee Y, Lim DG, Pai H. Int J Antimicrob Agents; 2018 May; 51(5):762-767. PubMed ID: 29408226 [Abstract] [Full Text] [Related] Page: [Next] [New Search]